Accéder au contenu
Merck

Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.

Stem cell research (2016-11-24)
Anne M Bara, Angelica Messana, Amanda Herring, Dane Z Hazelbaker, Kevin Eggan, Lindy E Barrett
RÉSUMÉ

Here, we generated a monoallelic mutation in the TLE3 (Transducin Like Enhancer of Split 3) gene using CRISPR-Cas9 editing in the human embryonic stem cell (hESC) line WA01. The heterozygous knockout cell line, TLE3-447-D08-A01, displays partial loss of TLE3 protein expression while maintaining pluripotency, differentiation potential and genomic integrity.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Roche
Cocktails d'inhibiteurs de protéases Mini cOmplete, Tablets provided in a glass vial
Sigma-Aldrich
Anticorps monoclonal anti-α-actine de muscle lisse, clone 1A4, ascites fluid
Sigma-Aldrich
Puromycine dihydrochloride from Streptomyces alboniger, ≥98% (HPLC), powder
Sigma-Aldrich
Monoclonal Anti-α-Fetoprotein (AFP) antibody produced in mouse, ascites fluid, clone C3